Redhill Biopharma Stock Doubles In One Session — Here's Why
RedHill Biopharma divests Talicia to Apotex, boosting liquidity and funding its commercial growth strategy and RHB-102 development.
RedHill Biopharma sold one of its medicines to another company and got cash back, which helps them keep going and work on new medicine. When a company gets money by selling something, it's like finding extra allowance—watch if they use it wisely on new products.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.